Newsletter | March 14, 2025

03.14.25 -- A CEO With A General Counsel's Perspective

NEW PODCAST EPISODE

BoB@JPM: Rick Modi, Affinia Therapeutics

On the latest episode of Business of Biotech, Affinia Therapeutics CEO Rick Modi shares how his Kenyan upbringing shaped his resilience, his transition from pharma to biotech, and the cutting-edge gene therapy work at Affinia. Recorded live at JPM in San Francisco, this conversation dives into leadership, innovation, and upcoming clinical trials. Listen now and subscribe so you don't miss an episode!

FROM THE EDITOR

A CEO With A General Counsel's Perspective

LB Pharmaceuticals CEO Heather Turner explains why 18 years as a general counsel provided her with an advantageous perspective on the CEO role.

INDUSTRY INSIGHTS

Antibody-Drug Conjugates: 'Magic Bullets' Become Reality

Cancer therapy has evolved from potent chemotherapy to targeted biological therapy, including ADCs. Learn more about their makeup, mechanisms, and the development landscape.

Streamline Early-Stage Development To Reach The Clinic Faster

Early-stage development is an iterative process, continuously generating new data and insights to optimize the product based on emerging knowledge.

Eco-Design Yields Sustainability Gains — Why Is It So Hard?

Explore some of the biggest obstacles companies are encountering and what is already being done to move the industry closer to significant sustainability progress and environmental achievements.

Data Integrity In Clinical Trials: The Role Of Advanced EDC Systems

How can Electronic Data Capture (EDC) tools streamline your data collection process and help you manage the increasing complexity and data?

How Pharmaceutical Companies Can Effectively Engage With PAOs

In this presentation, industry experts explain the role of PAOs, tips for pharmaceutical companies and PAOs to forge strong relationships, and techniques to integrate patient perspectives.

CONTRIBUTE TO LIFE SCIENCE LEADER

Article Submission Guidelines

Think you have a good idea for an article that Life Science Leader readers would find valuable?  Read these guidelines first before submitting your idea or your article to our editorial director.